A case of 3β-hydroxy-Δ5-C27-steroid oxidoreductase deficiency presenting as neonatal cholestasis

  • Published on

  • View

  • Download


Abstracts / Digestive and Liver Disease 39 (2007) A49A87 A69plete normalization of the liver function tests was achieved. He remainedclinically well and was discharged from the hospital at day 42 of life. Sub-sequently, he was treated with vitamin E for 6 months. He was completelyhealthy during a 12-month period of observation.Conclusions. There is no conclusive evidence about the effectivenessof the currentin this patienchildren affecdoi:10.1016/jPP 39A CASE OFDEFICIENCC. Amoruso aM.T. Dotti b,a Istituto di PMangiagalli eb Dipartimentdegli Studi dic Dipartimentd DipartimentOspedale SanCerebroteerror of primhydroxysteroiin plasma, urtraced to a mucataract, tendhood (over 20patients are venia have beensevere jaundicthis is the firsA femalehypocholic sttransferases awithin normation were coaetiologies ofobstructions,dromes, mostplasma and ursubstances, plogic, skeletaultrasonograpalteration of inwere found inLiver biopcellular and ihepatocellulaBiliary acprophile compCholestan(n.v. 470g/ddeletion of 1.9described in CTherapy wwith chenodeCholestasConclusio After havinfocus on ra Early diagnosis of CX is fundamental, considering that chenodeoxy-cholyc acid is an efficient therapy in this condition and can preventaccumulation of cholestanol in tissues with development of neurologicimpairmen.1016/jICTORYEARntiga acan a, Prtmentrtmenta, Italytute of Rrtmentrtmentcal Triaova, Itackgrouunreseransplant preparwaitingility, tots withethods.t 20 yeaement,ive treatliver afsults. Wed OLTyear suocalityIII or Iava (p =er age (s and thlanted.nclusiochemotts of olf majoection;lantatio.1016/jE LIVbili a, Smparcobino Geology Dratoryatric Deeasles iicationsic involmedical treatment for NH. The favourable outcome describedt suggests that EXT could be a feasible treatment option forted by NH, as it is for other alloimmune conditions..dld.2007.07.1013-HYDROXY-5-C27-STEROID OXIDOREDUCTASEY PRESENTING AS NEONATAL CHOLESTASIS, M. Fuoti a, V. Miceli a, R. Celano a, M. Pinotti a,G. Giordano c, M. Del Puppo d, M.S. Scotta a, G. Nebbia aediatria,Fondazione IRCCS Ospedale Maggiore Policlinico,Regina Elena, Milan, Italyo di Scienze Neurologiche e del Comportamento-Universita`Siena, Italyo di Pediatria-Universita` degli Studi di Padova, Italyo di Medicina Sperimentale-Universita` di Milano-Bicocca,tAntonio Abate-Gallarate, Itlayndineous xanthomatosis (CX) is an autosomal recessive inbornary biliary acids synthesis. The deficiency of 3-5-C27-d dehydrogenase is responsible of accumulation of cholestanoline and tissues in affected individuals; the disorder has beentation of the CYP27A1 gene. Most cases present with juvenileon xanthomas and a progressive neurologic disorder in adult-years of age). About 200 cases have been reported; paediatricry rare: neonatal cholestasis, steathorroea, diarrhoea, osteope-described. We report a case of CX in an infant presenting withe and increase of plasma aminotransferases. In our knowledge,t Italian case described in paediatric age.infant of 74 days of age presented slight hepatosplenomegaly,ools and a biochemical picture of moderate increase of amino-nd severe conjugated hyperbilirubinaemia, with gamma-GTl values. Other cholestasis indexes and hepatic synthetic func-mpletely in the normal range. We excluded most frequentneonatal and infant cholestasis: extrahepatic biliary tractinfectious agents, alpha1-antitrypsin deficiency, CDG syn-frequent other metabolic diseases (normal ammonia, lactate,ine amino acids, urine organic acids, sweat test, urine reducinglasma biliary acids), endocrinopathies. Neurologic, cardio-l and ophthalmic evaluations were all normal. Abdominalhy revealed only slightly brilliant liver, without any significanttrahepatic or extrahepatic biliary tract. No other abnormalitiesany other abdominal organ.sy was performed and revealed giant cell hepatitis with intra-ntracanalicular cholestasis, inflammatory changes and focalr necrosis.ids were performed in urine by mass spectrometry revealing aatible with a diagnosis of CX.ol dosage, performed by mass-spectrometry, was 3.140g/dll). Molecular genetic analysis revealed a homozygosis for akb in the CYP27A gene, responsible of the enzymatic defectX.ith UDCA, early undertaken in this child, was rapidly changedoxycholyc acid when the diagnosis was achieved.is completely regressed within the 6-month of life.n. In front of a case of neonatal cholestasis:g excluded the most frequent etiologies, we recommend tore inborn error of metabolism of biliary acids.doi:10PP 40PREDA 20-L. DAL. Zana Depab DepaPadovc Instid DepaItalye Depaf Cliniof PadBaremainliver tpatienon thesectabpatienMthe lasinvolvservatnativeRerequirthe 5-multifTEXTvena cyounglesiontranspCobinedpatienment oby restranspdoi:10PP 41ACUTTIONV. NoD. Coa Bamb Pathc Labod PediMcomplHepatt..dld.2007.07.102S OF UNRESECTABILITY IN HEPATOBLASTOMA:SINGLE CENTRE REPORT, F. Vallortigara a, U. Cillo b, E. Talenti c, M. Rugge d,. DallIgna e, G.L. De Salvo f, G. Perilongo aof Paediatrics, University of Padova, Italyof Surgery and Gastroenterological Sciences, University ofadiology, University of Padova, Italyof Oncological and Surgical Sciences, University of Padova,of Paediatric Surgery, University of Padova, Italyls andBiostatisticsUnit IstitutoOncologicoVeneto,Universitylynd. Approximately 20% of cases of hepatoblastoma (HB)ctable after preoperative chemotherapy (PC). In these patientstation (LT) should be performed 1 month after PC. However,ation and organ availability often lead to spend longer timelist. We aimed to find presenting features that predict unre-provide suggestions for early referral and listing for LT inhepatoblastoma.Notes, radiology films and histology of patients managed inrs were reviewed. Unfeasible resection was defined by bilobarvascular extension or metastatic disease after PC. Failed con-ment (FCT) refers to cases that are not disease-free with theirter at least 1 year from surgery.e studied 28 patients, of whom 14 had a resection whereas 10. Four had no surgery because of tumour progression. Overallrvival is 76% (95% CI: 54.889.0). Predictors of FCT were(p = 0.006), high pre-treatment extent of tumour score (PRE-V) (p = 0.006), portal vein (p = 0.02), hepatic vein (p = 0.02) or0.05) involvement. Patients cured by resection presented at amedian of 0.7 vs. 4.2 years; p = 0.02). Patients with multifocalose with alpha-fetoprotein (FP)


View more >